Sotera Health posts Q3 2026 earnings beat and reaffirms full‑year outlook

Sotera Health reported third‑quarter 2026 results with adjusted EPS of $0.29, topping analyst estimates by $0.02. Revenue reached $324.89 million, a 4.4% year‑over‑year increase and above consensus. The company said operating margin held at 35.9% and free‑cash‑flow margin rose to 17.8%. It also reaffirmed its full‑year 2026 revenue and EPS guidance.

The earnings beat and the reaffirmed FY‑2026 guidance suggest the company expects to maintain its performance trajectory, which may support investor confidence. The beat also triggered a notable share price jump, indicating market reaction to the results.

Sources